Remove 2022 Remove Clinical Pharmacology Remove Immunity
article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

Cannabis complications There are notable complexities to researching medical cannabis using a linear approach to clinical translation. 5 These compounds have been shown in pre-clinical studies to have an array of potential effects on the immune, nervous, cardiovascular, respiratory and endocrine systems. 2022 Jan;56:8-14.

article thumbnail

Lipid Nanoparticles Immunogenicity & Toxicity | December 6-8, 2022

pharmaphorum

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. . Download the full event guide to find out more.

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. Hatfield Economic Fellow at Cornell University in 2022. She was also selected as the 39th Robert S.